Altered expression levels of miR-144-3p and ATP1B2 are associated with schizophrenia

References

• Alkan E, Davies G, Greenwood K, Evans SLH. 2020. Brain structural correlates of metacognition in first-episode psychosis. Schizophr Bull. 46(3):552–561.
   PubMed Web of Science ®Google Scholar
• Alnæs D, Kaufmann T, van der Meer D, Córdova-Palomera A, Rokicki J, Moberget T, Bettella F, Agartz I, Barch DM, Bertolino A, et al. 2019. Brain heterogeneity in schizophrenia and its association with polygenic risk. JAMA Psychiatry. 76(7):739–748.
   PubMed Web of Science ®Google Scholar
• Antonicek H, Persohn E, Schachner M. 1987. Biochemical and functional characterization of a novel neuron-glia adhesion molecule that is involved in neuronal migration. J Cell Biol. 104(6):1587–1595.
   PubMed Web of Science ®Google Scholar
• Bettio LE, Cunha MP, Budni J, Pazini FL, Oliveira A, Colla AR, Rodrigues AL. 2012. Guanosine produces an antidepressant-like effect through the modulation of nmda receptors, nitric oxide-cgmp and PI3K/mTOR pathways. Behav Brain Res. 234(2):137–148.
   PubMed Web of Science ®Google Scholar
• Boer K, Spliet WG, van Rijen PC, Jansen FE, Aronica E. 2010. Expression patterns of amog in developing human cortex and malformations of cortical development. Epilepsy Res. 91(1):84–93.
   PubMed Web of Science ®Google Scholar
• Boer K, Troost D, Timmermans W, van Rijen PC, Spliet WG, Aronica E. 2010. PI3K-mTOR signaling and amog expression in epilepsy-associated glioneuronal tumors. Brain Pathol. 20(1):234–244.
   PubMed Web of Science ®Google Scholar
• Cai H, Xue Y, Wang P, Wang Z, Li Z, Hu Y, Li Z, Shang X, Liu Y. 2015. The long noncoding RNA TUG1 regulates blood-tumor barrier permeability by targeting miR-144. Oncotarget. 6(23):19759–19779.
   PubMedGoogle Scholar
• Chadha R, Meador-Woodruff JH. 2020. Downregulated AKT-mTOR signaling pathway proteins in dorsolateral prefrontal cortex in schizophrenia. Neuropsychopharmacology. 45(6):1059–1067.
   PubMed Web of Science ®Google Scholar
• Dinan TG. 2010. Micrornas as a target for novel antipsychotics: a systematic review of an emerging field. Int J Neuropsychopharmacol. 13(3):395–404.
   PubMed Web of Science ®Google Scholar
• Dore LC, Amigo JD, Dos Santos CO, Zhang Z, Gai X, Tobias JW, Yu D, Klein AM, Dorman C, Wu W, et al. 2008. A GATA-1-regulated microrna locus essential for erythropoiesis. Proc Natl Acad Sci U S A. 105(9):3333–3338.
   PubMed Web of Science ®Google Scholar
• Fang X, Shen F, Lechauve C, Xu P, Zhao G, Itkow J, Wu F, Hou Y, Wu X, Yu L, et al. 2018. miR-144/451 represses the LKB1/AMPK/mTOR pathway to promote red cell precursor survival during recovery from acute anemia. Haematologica. 103(3):406–416.
   PubMed Web of Science ®Google Scholar
• Ghafouri-Fard S, Eghtedarian R, Taheri M, Beatrix Bruhl A, Sadeghi-Bahmani D, Brand S. 2021. A review on the expression pattern of non-coding RNAs in patients with schizophrenia: with a special focus on peripheral blood as a source of expression analysis. Front Psychiatry. 12:640463.
   PubMed Web of Science ®Google Scholar
• Gibbons A, Udawela M, Dean B. 2018. Non-coding RNA as novel players in the pathophysiology of schizophrenia. ncRNA. 4(2):11.
   Google Scholar
• Hsiung MH, Huang WL, Kan LY, Chen LH, Hu SS. 2020. The facilitating effect of MK-801 on inhibitory avoidance memory via mtor signaling in the mouse hippocampus. Behav Brain Res. 389:112630.
   PubMed Web of Science ®Google Scholar
• Hýža M, Kuhn M, Češková E, Ustohal L, Kašpárek T. 2016. Hippocampal volume in first-episode schizophrenia and longitudinal course of the illness. World J Biol Psychiatry. 17(6):429–438.
   PubMed Web of Science ®Google Scholar
• Jiang Q, Xie Q, Hu C, Yang Z, Huang P, Shen H, Schachner M, Zhao W. 2019. Glioma malignancy is linked to interdependent and inverse AMOG and L1 adhesion molecule expression. BMC Cancer. 19(1):911.
   PubMed Web of Science ®Google Scholar
• Kahn RS, Sommer IE. 2015. The neurobiology and treatment of first-episode schizophrenia. Mol Psychiatry. 20(1):84–97.
   PubMed Web of Science ®Google Scholar
• Khavari B, Cairns MJ. 2020. Epigenomic dysregulation in schizophrenia: in search of disease etiology and biomarkers. Cells. 9(8):1837.
   PubMed Web of Science ®Google Scholar
• Kloosterman WP, Wienholds E, de Bruijn E, Kauppinen S, Plasterk RHA. 2006. In situ detection of miRNAs in animal embryos using LNA-modified oligonucleotide probes. Nat Methods. 3(1):27–29.
   PubMed Web of Science ®Google Scholar
• Kooshkaki O, Rezaei Z, Rahmati M, Vahedi P, Derakhshani A, Brunetti O, Baghbanzadeh A, Mansoori B, Silvestris N, Baradaran B. 2020. MiR-144: a new possible therapeutic target and diagnostic/prognostic tool in cancers. IJMS. 21(7):2578.
   Google Scholar
• Lecuona E, Luquin S, Avila J, Garcia-Segura LM, Martin-Vasallo P. 1996. Expression of the beta 1 and beta 2(AMOG) subunits of the Na,K-ATPase in neural tissues: cellular and developmental distribution patterns. Brain Res Bull. 40(3):167–174.
   PubMed Web of Science ®Google Scholar
• Li K, Zhang J, Ji C, Wang L. 2016. MiR-144-3p and its target gene beta-amyloid precursor protein regulate 1-methyl-4-phenyl-1,2-3,6-tetrahydropyridine-induced mitochondrial dysfunction. Mol Cells. 39(7):543–549.
   PubMed Web of Science ®Google Scholar
• Litan A, Li Z, Tokhtaeva E, Kelly P, Vagin O, Langhans SA. 2019. A functional interaction between Na,K-ATPase beta2-subunit/AMOG and NF2/merlin regulates growth factor signaling in cerebellar granule cells. Mol Neurobiol. 56(11):7557–7571.
   PubMed Web of Science ®Google Scholar
• Mabunga DFN, Park D, Ryu O, Valencia ST, Adil KJL, Kim S, Kwon KJ, Shin CY, Jeon SJ. 2019. Recapitulation of neuropsychiatric behavioral features in mice using acute low-dose MK-801 administration. Exp Neurobiol. 28(6):697–708.
   PubMed Web of Science ®Google Scholar
• McCutcheon RA, Reis Marques T, Howes OD. 2020. Schizophrenia-an overview. JAMA Psychiatry. 77(2):201–210.
   PubMed Web of Science ®Google Scholar
• Neis VB, Moretti M, Rosa PB, Dalsenter YO, Werle I, Platt N, Kaufmann FN, Rosado AF, Besen MH, Rodrigues ALS. 2020. The involvement of PI3k/Akt/mTOR/GSK3beta signaling pathways in the antidepressant-like effect of AZD6765. Pharmacol Biochem Behav. 198:173020.
   PubMed Web of Science ®Google Scholar
• Pan B, Deng C. 2019. Modulation by chronic antipsychotic administration of PKA- and GSK3beta-mediated pathways and the NMDA receptor in rat ventral midbrain. Psychopharmacology (Berl). 236(9):2687–2697.
   PubMed Web of Science ®Google Scholar
• Pan B, Huang XF, Deng C. 2016. Chronic administration of aripiprazole activates GSK3beta-dependent signalling pathways, and up-regulates GABAA receptor expression and CREB1 activity in rats. Sci Rep. 6:30040.
   PubMed Web of Science ®Google Scholar
• Pan B, Lian J, Deng C. 2018. Chronic antipsychotic treatment differentially modulates protein kinase A- and glycogen synthase kinase 3 beta-dependent signaling pathways, N-methyl-D-aspartate receptor and gamma-aminobutyric acid A receptors in nucleus accumbens of juvenile rats. J Psychopharmacol. 32(11):1252–1263.
   PubMed Web of Science ®Google Scholar
• Park SW, Lee JG, Seo MK, Lee CH, Cho HY, Lee BJ, Seol W, Kim YH. 2014. Differential effects of antidepressant drugs on mtor signalling in rat hippocampal neurons. Int J Neuropsychopharmacol. 17(11):1831–1846.
   PubMed Web of Science ®Google Scholar
• Pasquinelli AE. 2012. Micrornas and their targets: recognition, regulation and an emerging reciprocal relationship. Nat Rev Genet. 13(4):271–282.
   PubMed Web of Science ®Google Scholar
• Paxinos G, Watson C. 2007. The rat brain in stereotaxic coordinates. 6th ed. San Diego (CA): Elsevier Academic Press.
   Google Scholar
• Pina-Camacho L, Del Rey-Mejías Á, Janssen J, Bioque M, González-Pinto A, Arango C, Lobo A, Sarró S, Desco M, Sanjuan J, et al. 2016. Age at first episode modulates diagnosis-related structural brain abnormalities in psychosis. Schizophr Bull. 42(2):344–357.
   PubMed Web of Science ®Google Scholar
• Raheja R, Regev K, Healy BC, Mazzola MA, Beynon V, Von Glehn F, Paul A, Diaz-Cruz C, Gholipour T, Glanz BI, et al. 2018. Correlating serum micrornas and clinical parameters in amyotrophic lateral sclerosis. Muscle Nerve. 58(2):261–269.
   PubMed Web of Science ®Google Scholar
• Rasmussen KD, Simmini S, Abreu-Goodger C, Bartonicek N, Di Giacomo M, Bilbao-Cortes D, Horos R, Von Lindern M, Enright AJ, O’Carroll D. 2010. The mir-144/451 locus is required for erythroid homeostasis. J Exp Med. 207(7):1351–1358.
   PubMed Web of Science ®Google Scholar
• Richetto J, Meyer U. 2021. Epigenetic modifications in schizophrenia and related disorders: molecular scars of environmental exposures and source of phenotypic variability. Biol Psychiatry. 89(3):215–226.
   PubMed Web of Science ®Google Scholar
• Rotoli D, Cejas MM, Maeso MD, Perez-Rodriguez ND, Morales M, Avila J, Mobasheri A, Martin-Vasallo P. 2017. The Na, K-ATPase beta-subunit isoforms expression in glioblastoma multiforme: Moonlighting roles. IJMS. 18(11):2369.
   Google Scholar
• Ryskalin L, Lazzeri G, Flaibani M, Biagioni F, Gambardella S, Frati A, Fornai F. 2017. mTOR-dependent cell proliferation in the brain. Biomed Res Int. 2017:7082696.
   PubMed Web of Science ®Google Scholar
• Safari MR, Komaki A, Arsang-Jang S, Taheri M, Ghafouri-Fard S. 2019. Expression pattern of long non-coding RNAs in schizophrenic patients. Cell Mol Neurobiol. 39(2):211–221.
   PubMed Web of Science ®Google Scholar
• Scheidenhelm DK, Cresswell J, Haipek CA, Fleming TP, Mercer RW, Gutmann DH. 2005. Akt-dependent cell size regulation by the adhesion molecule on glia occurs independently of phosphatidylinositol 3-kinase and rheb signaling. Mol Cell Biol. 25(8):3151–3162.
   PubMed Web of Science ®Google Scholar
• Sun MZ, Kim JM, Oh MC, Safaee M, Kaur G, Clark AJ, Bloch O, Ivan ME, Kaur R, Oh T, et al. 2013. Na(+)/K(+)-ATPase beta2-subunit (AMOG) expression abrogates invasion of glioblastoma-derived brain tumor-initiating cells. Neuro Oncol. 15(11):1518–1531.
   PubMed Web of Science ®Google Scholar
• Tatura R, Kraus T, Giese A, Arzberger T, Buchholz M, Hoglinger G, Muller U. 2016. Parkinson’s disease: SNCA-, PARK2-, and LRRK2- targeting microRNAs elevated in cingulate gyrus. Parkinsonism Relat Disord. 33:115–121.
   PubMed Web of Science ®Google Scholar
• Vanderplow AM, Eagle AL, Kermath BA, Bjornson KJ, Robison AJ, Cahill ME. 2021. Akt-mTOR hypoactivity in bipolar disorder gives rise to cognitive impairments associated with altered neuronal structure and function. Neuron. 109(9):1479–1496 e1476.
   PubMed Web of Science ®Google Scholar
• Venkatesh HS, Tam LT, Woo PJ, Lennon J, Nagaraja S, Gillespie SM, Ni J, Duveau DY, Morris PJ, Zhao JJ, et al. 2017. Targeting neuronal activity-regulated neuroligin-3 dependency in high-grade glioma. Nature. 549(7673):533–537.
   PubMed Web of Science ®Google Scholar
• Wang L, Zhou K, Fu Z, Yu D, Huang H, Zang X, Mo X. 2017. Brain development and Akt signaling: The crossroads of signaling pathway and neurodevelopmental diseases. J Mol Neurosci. 61(3):379–384.
   PubMed Web of Science ®Google Scholar
• Wang ZM, Dong XY, Cong SY. 2020. Bioinformatic analysis of a microrna regulatory network in Huntington’s disease. J Integr Neurosci. 19(4):641–650.
   PubMed Web of Science ®Google Scholar
• Wu H, Wang X, Gao Y, Lin F, Song T, Zou Y, Xu L, Lei H. 2016. NMDA receptor antagonism by repetitive MK801 administration induces schizophrenia-like structural changes in the rat brain as revealed by voxel-based morphometry and diffusion tensor imaging. Neuroscience. 322:221–233.
   PubMed Web of Science ®Google Scholar
• Xing RX, Li LG, Liu XW, Tian BX, Cheng Y. 2020. Down regulation of miR-218, miR-124, and miR-144 relates to parkinson’s disease via activating NF-kappaB signaling. Kaohsiung J Med Sci. 36(10):786–792.
   PubMed Web of Science ®Google Scholar
• Zhao S, Shao L, Wang Y, Meng Q, Yu J. 2020. Ketamine exhibits anti-gastric cancer activity via induction of apoptosis and attenuation of PI3K/Akt/mTOR. Arch Med Sci. 16(5):1140–1149.
   PubMed Web of Science ®Google Scholar
• Zhou LT, Zhang J, Tan L, Huang HZ, Zhou Y, Liu ZQ, Lu Y, Zhu LQ, Yao C, Liu D. 2021. Elevated levels of miR-144-3p induce cholinergic degeneration by impairing the maturation of ngf in Alzheimer’s disease. Front Cell Dev Biol. 9:667412.
   PubMedGoogle Scholar
• Zhou M, Wu Y, Li H, Zha X. 2020. MicroRNA-144: a novel biological marker and potential therapeutic target in human solid cancers. J Cancer. 11(22):6716–6726.
   PubMed Web of Science ®Google Scholar
• Zhou Q, Luo L, Wang X, Li X. 2019. Relationship between single nucleotide polymorphisms in the 3'UTR of amyloid precursor protein and risk of Alzheimer’s disease and its mechanism. Biosci Rep. 39(5):BSR20182485.
   PubMedGoogle Scholar